Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.13, $0.17 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $124.6 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.